Login

Abbott India Ltd.

₹29398.95

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Abbott India Ltd.

₹29398.95

₹29398.95

433.25 (1.5%) - 8 Apr 2025 04:26 PM

About Company

Abbott India Limited, a publicly listed company and a subsidiary of Abbott Laboratories, offers high-quality trusted medicines in multiple therapeutic categories such as women’s health, gastroenterology, cardiology, metabolic disorders and primary care. It is one of India's fastest-growing pharmaceutical companies. It has expertise across product development, manufacturing, sales and customer service and are dedicated to providing high-quality, reliable products with the expert clinical support its customers need. The company’s in-house development and medical teams undertake product and clinical development tailored to the unique needs of the Indian market.

Market Cap. ₹61,550 Cr.
52 Week - High/Low ₹31,899/25,200
P/E Ratio 46.12
P/B Ratio 16.64
Enterprise Value ₹59,552 Cr.
ROE % 35.31
RSI Value 40.66
EMA 50 29610.54
EMA 200 28458.96
Net Profit 1,201 Cr.
Net Profit 3year growth 73.92 Cr.
Net Profit 3 year (back) 691 Cr.
Debt to Equity 0.0 %
EPS Growth TTM 16.49 %
Current Ratio 2.42 %
100 Day SMA 28,844 Rs.
200 Day SMA 28,659 Rs.
21 Day SMA 30,232 Rs.
50 Day SMA 29,223 Rs.
Book Value 1,741 Rs.
EV/EBITDA Ratio 32
QoQ EPS Growth 1 %
QoQ Operating Profit Growth -1 %
QoQ Sales Growth -1 %
Sales Latest Quarter 1,614 Cr.
YoY Sales Growth 12 %
Market Cap. ₹61,550 Cr.
52 Week - High/Low ₹31,899/25,200
P/E Ratio N/A
P/B Ratio N/A
Enterprise Value -
ROE % 37.45
RSI Value 40.66
EMA 50 29610.54
EMA 200 28458.96
Net Profit 50 Cr.
Net Profit 3year growth N/A
Net Profit 3 year (back) N/A
Debt to Equity 0.02 %
EPS Growth TTM N/A
Current Ratio 1.06 %
100 Day SMA 28,844 Rs.
200 Day SMA 28,659 Rs.
21 Day SMA 30,232 Rs.
50 Day SMA 29,223 Rs.
Book Value N/A
EV/EBITDA Ratio N/A
QoQ EPS Growth N/A
QoQ Operating Profit Growth N/A
QoQ Sales Growth N/A
Sales Latest Quarter N/A
YoY Sales Growth N/A
Add Parameters

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.